Only thing that matters25 Sep 2025 07:31
Based on FDA feedback and de-risking from a 230+ subject proof-of-concept study, the Company now expects the trial to be significantly smaller and completed at an estimated cost of US$4.0m to US$4.5m, down from prior estimates of US$9.0m to US$11.0m.. no need for a raise, so all u idiots cab now go bk to ur holes)